These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23973042)

  • 41. Myeloperoxidase may help to differentiate coronary plaque erosion from plaque rupture in patients with acute coronary syndromes.
    Niccoli G; Dato I; Crea F
    Trends Cardiovasc Med; 2010 Nov; 20(8):276-81. PubMed ID: 22433655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathology of plaque haemorrhage and neovascularization of coronary artery.
    Kodama T; Narula N; Agozzino M; Arbustini E
    J Cardiovasc Med (Hagerstown); 2012 Oct; 13(10):620-7. PubMed ID: 22828775
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noninvasive imaging of arterial inflammation using FDG-PET/CT.
    Emami H; Tawakol A
    Curr Opin Lipidol; 2014 Dec; 25(6):431-7. PubMed ID: 25340479
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Should we begin with statin therapy in acute coronary syndrome?].
    Reiner Z
    Acta Med Croatica; 2004; 58(2):147-50. PubMed ID: 15208802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Review on treatment of unstable atherosclerotic plaque with traditional Chinese medicine].
    Zhou MX; Xu H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 May; 26(5):472-4. PubMed ID: 16883920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Addressing Acute Coronary Syndromes: New Challenges and Opportunities After the CANTOS Trial (Canakinumab Anti-inflammatory Thrombosis Outcomes Study).
    Crea F; Liuzzo G
    Circulation; 2018 Mar; 137(11):1100-1102. PubMed ID: 29530890
    [No Abstract]   [Full Text] [Related]  

  • 47. A systematic review of the time course of atherosclerotic plaque regression.
    Noyes AM; Thompson PD
    Atherosclerosis; 2014 May; 234(1):75-84. PubMed ID: 24632041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How do we prevent the vulnerable atherosclerotic plaque from rupturing? Insights from in vivo assessments of plaque, vascular remodeling, and local endothelial shear stress.
    Andreou I; Antoniadis AP; Shishido K; Papafaklis MI; Koskinas KC; Chatzizisis YS; Coskun AU; Edelman ER; Feldman CL; Stone PH
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):261-75. PubMed ID: 25336461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of acute coronary syndromes and the potential role of statins.
    Dupuis J
    Atheroscler Suppl; 2001 Feb; 2(1):9-14. PubMed ID: 11286155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Unstable atheromatous plaque. Physiopathology and therapeutic approach to coronary insufficiency].
    Berkenboom G
    Rev Med Brux; 2001 Dec; 22(6):497-502. PubMed ID: 11811045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid levels after acute coronary syndromes.
    Pitt B; Loscalzo J; Ycas J; Raichlen JS
    J Am Coll Cardiol; 2008 Apr; 51(15):1440-5. PubMed ID: 18402897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of Colchicine in Coronary Artery Disease.
    Butt AK; Cave B; Maturana M; Towers WF; Khouzam RN
    Curr Probl Cardiol; 2021 Mar; 46(3):100690. PubMed ID: 32994053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Matrix metalloproteinase inhibition with tetracyclines for the treatment of coronary artery disease.
    Bench TJ; Jeremias A; Brown DL
    Pharmacol Res; 2011 Dec; 64(6):561-6. PubMed ID: 21624471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Darapladib for the treatment of cardiovascular disease.
    Campos CM; Suwannasom P; Koenig W; Serruys PW; Garcia-Garcia HM
    Expert Rev Cardiovasc Ther; 2015 Jan; 13(1):33-48. PubMed ID: 25521799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validating the benefits of lipid modifying therapies upon atherosclerotic plaque by computed tomography angiography: should we trust our eyes? Commentary on the study of Zeb et al.
    Rached FH; Santos RD
    Atherosclerosis; 2013 Dec; 231(2):189-90. PubMed ID: 24267224
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of inflammation and allergy in acute coronary syndromes.
    Ozben B; Erdogan O
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):136-44. PubMed ID: 18782020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advances in mechanisms, imaging and management of the unstable plaque.
    Niccoli G; Liuzzo G; Montone RA; Crea F
    Atherosclerosis; 2014 Apr; 233(2):467-477. PubMed ID: 24530781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathophysiological role of neutrophils in acute myocardial infarction.
    Carbone F; Nencioni A; Mach F; Vuilleumier N; Montecucco F
    Thromb Haemost; 2013 Sep; 110(3):501-14. PubMed ID: 23740239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug therapies to prevent coronary plaque rupture and erosion: present and future.
    Kovanen PT; Mäyranpää M; Lindstedt KA
    Handb Exp Pharmacol; 2005; (170):745-76. PubMed ID: 16596822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vulnerable plaque derived from aspirated thrombi in recurrent acute coronary syndrome with familial hypercholesterolemia despite intensive lipid-lowering statin therapy.
    Natsui H; Konishi T; Saiin K; Tamaki Y; Sato T; Takenaka S; Tada A; Mizuguchi Y; Kobayashi Y; Sato T; Kamada R; Kamiya K; Nagai T; Tanaka S; Anzai T
    Cardiol J; 2022; 29(2):362-363. PubMed ID: 35411933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.